Home Cart Sign in  
Chemical Structure| 37064-30-5 Chemical Structure| 37064-30-5

Structure of Procyanidin C1
CAS No.: 37064-30-5

Chemical Structure| 37064-30-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Procyanidin C1 is a natural polyphenol with anti-tumor and antioxidant properties. It induces cell cycle arrest and apoptosis, showing significant efficacy in various cancer models.

Synonyms: PCC1; Proanthocyanidin C1; Procyanidol C1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Procyanidin C1

CAS No. :37064-30-5
Formula : C45H38O18
M.W : 866.77
SMILES Code : O[C@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=C(C(O)=CC(O)=C3)[C@@H]1C4=C(O)C=C(O)C5=C4O[C@H](C6=CC=C(O)C(O)=C6)[C@H](O)[C@H]5C7=C(O)C=C(O)C8=C7O[C@H](C9=CC=C(O)C(O)=C9)[C@H](O)C8
Synonyms :
PCC1; Proanthocyanidin C1; Procyanidol C1
MDL No. :MFCD01682743
InChI Key :MOJZMWJRUKIQGL-XILRTYJMSA-N
Pubchem ID :169853

Safety of Procyanidin C1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Procyanidin C1

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MSCs 100 µM 3 days PCC1 selectively eliminates senescent cells by inducing apoptosis. Nat Metab. 2021 Dec;3(12):1706-1726
HUVECs 100 µM 3 days PCC1 selectively eliminates senescent cells by inducing apoptosis. Nat Metab. 2021 Dec;3(12):1706-1726
HT22 cells 5 and 10 µM 12 hours To evaluate the preventive effect of PC-1 against glutamate-induced apoptosis in HT22 cells. Results showed that PC-1 significantly reduced glutamate-induced chromatin condensation and the number of annexin V-positive cells. Int J Mol Sci. 2019 Jan 2;20(1):142
RAW 264.7 macrophages 10 and 100 µM 2 hours pretreatment followed by 24 hours LPS stimulation To evaluate the inhibitory effect of Procyanidin C1 on LPS-induced inflammatory responses. Results showed that Procyanidin C1 significantly inhibited LPS-induced NO production and the expression of iNOS and COX-2. Molecules. 2023 Mar 20;28(6):2813
Human nucleus pulposus cells 10, 20, 40 µM 24 hours PCC1 pretreatment significantly improved cell viability and reversed acidic pH stress-induced changes in extracellular matrix metabolism. J Transl Med. 2024 Nov 27;22(1):1071
RAW 264.7 macrophage cell line 50 µM 24 hours To evaluate the senolytic and anti-inflammatory effects of PCC1 on senescent cells. Results showed that PCC1 significantly reduced β-galactosidase-positive cells, decreased TNF-α and IL-6 levels, and induced apoptosis in senescent cells. NPJ Aging. 2025 May 2;11(1):31
HT22 cells 5 and 10 µM 24 hours To assess the neuroprotective effects of PC-1 against glutamate-induced HT22 cell death. Results showed that PC-1 significantly reduced glutamate-induced cell death. Int J Mol Sci. 2019 Jan 2;20(1):142
Whipworm (Trichuris trichiura) larvae 50.4 µg/mL (41.0–62.9) 24 hours Evaluate the anthelmintic activity of Procyanidin C1 against whipworm larvae, showing significant activity in the unfermented state. Front Pharmacol. 2024 Jul 22;15:1390500
HCT116 5 µM and 10 µM 24, 48, and 72 hours PCC1 inhibited CRC cell proliferation, migration, and invasion by suppressing miR-501-3p and upregulating HIGD1A expression J Adv Res. 2024 Jun;60:215-231
DLD1 5 µM and 10 µM 24, 48, and 72 hours PCC1 inhibited CRC cell proliferation, migration, and invasion by suppressing miR-501-3p and upregulating HIGD1A expression J Adv Res. 2024 Jun;60:215-231
WI38 cells 100 µM 3 days PCC1 selectively eliminates senescent cells by inducing apoptosis. Nat Metab. 2021 Dec;3(12):1706-1726
PSC27 cells 50 µM 3 days PCC1 selectively eliminates senescent cells by inducing apoptosis and exacerbating mitochondrial stress. Nat Metab. 2021 Dec;3(12):1706-1726
INS-1 cells 12.5–50 µM 48 hours Procyanidin C1 dose-dependently increased cell viability and decreased ROS accumulation in H2O2-treated β-cells. Acta Pharmacol Sin. 2016 Aug;37(8):1083-90
HT22 cells 5 and 10 µM 6 hours To evaluate the effect of PC-1 on Nrf2 nuclear translocation and HO-1 expression. Results showed that PC-1 significantly increased nuclear translocation of Nrf2 and expression of HO-1. Int J Mol Sci. 2019 Jan 2;20(1):142
Na+,K+-ATPase 4.5 µM 6 minutes To investigate the inhibitory effect of Procyanidin C1 on Na+,K+-ATPase, results showed an IC50 of 4.5 µM. Sci Rep. 2022 Apr 29;12(1):7011
Caenorhabditis elegans (L4) 170 µg/mL (196.2 µM) 72 hours Evaluate the anthelmintic activity of Procyanidin C1 against C. elegans, showing significantly reduced activity after fermentation. Front Pharmacol. 2024 Jul 22;15:1390500
Hookworm larvae 60.9 µg/mL (46.7–80.6) 72 hours Evaluate the anthelmintic activity of Procyanidin C1 against hookworm larvae, showing significant activity in the unfermented state. Front Pharmacol. 2024 Jul 22;15:1390500
HT22 cells 5 and 10 µM 8 hours To assess the effect of PC-1 on glutamate-induced MAPK activation. Results showed that PC-1 significantly reduced phosphorylation of ERK1/2 and p38. Int J Mol Sci. 2019 Jan 2;20(1):142
HT22 cells 5 and 10 µM 8 hours To assess the effect of PC-1 on glutamate-induced intracellular ROS accumulation. Results showed that PC-1 almost completely blocked the glutamate-induced increase in ROS. Int J Mol Sci. 2019 Jan 2;20(1):142

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NSG mice Peritoneal metastasis model Intraperitoneal injection 20 mg/kg Every 2 days for 60 days Evaluate the inhibitory effect of Procyanidin C1 combined with 5-FU on peritoneal metastasis, results showed combined treatment significantly inhibited peritoneal metastasis and prolonged survival Clin Transl Med. 2023 Nov;13(11):e1481
Mice NOD-SCID mice Intraperitoneal injection 20 mg/kg Biweekly for 8 weeks PCC1 significantly reduces tumor size and prolongs survival by clearing senescent cells and inhibiting SASP expression. Nat Metab. 2021 Dec;3(12):1706-1726
NOD-SCID gamma (NSG) mice Breast cancer and gastric cancer models Intraperitoneal injection 20 mg/kg Once daily for 20 days Evaluate the inhibitory effect of PCC1 on matCAF and its impact on tumor growth Clin Transl Med. 2023 Dec;13(12):e1516
BALB/c nude mice CRC cell xenograft model Intraperitoneal injection 20 mg/kg and 40 mg/kg Once every 3 days PCC1 significantly inhibited tumor growth and metastasis by modulating the miR-501-3p/HIGD1A axis J Adv Res. 2024 Jun;60:215-231
Zebrafish Parkinson's disease model Water bath 25 µM 4 days To evaluate the protective effect of Procyanidin C1 on the zebrafish Parkinson's disease model. The results showed that 25 μM Procyanidin C1 significantly improved the exercise capacity of zebrafish, reduced the damage to dopaminergic neurons, and upregulated the expression of Nrf2, NQO1, and HO-1 genes. Molecules. 2022 Aug 6;27(15):5007
C57BL/6J male mice Aged mouse model Oral 3.2 mg/kg/day Once daily for 4 months To assess the geroprotective effects of PCC1 on the hematopoietic immune system in aged mice. Results demonstrated that PCC1 significantly improved grip strength, reduced senescent cell burden, suppressed inflammatory responses, and restored immune homeostasis. NPJ Aging. 2025 May 2;11(1):31
Mice Natural aging model (18-20 months old) Oral (diet mixture) 8 mg/kg (mixed in standard diet) Continued for 4 months PCC1 reversed structural and functional decline in aged retina by clearing senescent cells and inhibiting SASP Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2311028121
Sprague-Dawley rats Tail disc degeneration model Intraperitoneal injection 8 mg/kg/day Once daily for 8 weeks PCC1 treatment significantly alleviated histopathological changes of intervertebral disc degeneration and preserved the extracellular matrix of nucleus pulposus cells. J Transl Med. 2024 Nov 27;22(1):1071

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.15mL

0.23mL

0.12mL

5.77mL

1.15mL

0.58mL

11.54mL

2.31mL

1.15mL

 

Historical Records

Categories